Biotechnology & Pharmaceuticals

BSc (Hons), Fellow of the Chartered Institute of Patent Agents, Registered UK and European Trade Mark Attorney, European Patent Attorney, Patent Agent Litigator, Member of AIPPI, LES, SCI and Patent Agent Litigators Society. Also, past or present tutor in the EPI training programme for the European Qualifying Examination.

Philip read microbiology and virology at the University of Warwick. He worked in private practice specialising in the chemical and biotechnology fields before joining Potter Clarkson in 1994. He became a partner in 1998 and joined the Board of Management in January 2006.

BSc, PhD, Fellow of the Chartered Institute of Patent Attorneys, European Patent Attorney.

John read biochemistry at Bristol University. He conducted research in microbial molecular biology at Sheffield University for his doctorate, and did post-doctoral research work on mammalian cytochrome P450 genes for Cancer Research UK at Edinburgh University. During his research career, John authored over forty research and review papers for international journals in the fields of biochemistry, molecular biology and genetics.

BSc (Hons), MSc, PhD, Fellow of the Chartered Institute of Patent Attorneys, European Patent Attorney.

Steve studied chemistry at the University of Manchester before obtaining a doctorate in organic chemistry from the same university. He worked in the research department of a large UK chemical company before joining the patent department of an international pharmaceutical company.

MA (Oxon), Fellow of the Chartered Institute of Patent Attorneys, European Patent Attorney, Member of the Royal Society of Chemistry.

Ian read chemistry at Oxford University, after which he worked in the research department of a large multinational company as a synthetic organic chemist. Ian entered the patent profession in 1990 and worked in private practice before joining Potter Clarkson in 1999. He became a partner in 2000.

MA (Cantab), PhD, Fellow of the Chartered Institute of Patent Attorneys, European Patent Attorney, Member of Biochemistry Society and CIPA Life Sciences Committee.

Stephanie read natural sciences (biochemistry) at Trinity College, Cambridge, before completing a PhD in molecular biology at the Medical Research Councils Laboratory of Molecular Biology in Cambridge.

MA (Oxon), DPhil, Fellow of the Chartered Institute of Patent Attorneys, European Patent Attorney.

Steve read biochemistry at the University of Oxford before undertaking a doctorate degree in neuroscience at the University's Department of Clinical Pharmacology. During his doctorate studies, Steve spent several months on secondment at the Karolinska Hospital in Stockholm. After completing his doctorate, Steve remained in Oxford and spent three years as a post-doctoral scientist and authored a number of scientific papers.

BSc (Hons), PhD, Fellow of the Chartered Institute of Patent Attorneys and European Patent Attorney, Member of AIPLA, China Britain Business Council, The Research & Development Society and the Intellectual Property Institute. Past tutor in the EPI training programme for the European Qualifying Examinations.

Charlotte read chemistry at University College London and obtained a PhD in organometallic chemistry from Cambridge University.

MA (Oxon), DPhil, Member of the Royal Society of Chemistry, Fellow of the Chartered Institute of Patent Attorneys, European Patent Attorney.

Mike read chemistry at Oxford University before obtaining a DPhil in biomimetic co-ordination chemistry from the same university. After spending a year at the Max-Planck Institut für Strahlenchemie, as a post-doctoral researcher funded by the Royal Society, he then worked as a researcher in the fuel cells group of a large precious metals company.

BSc (Hons), DPhil (Oxon), Fellow of the Chartered Institute of Patent Attorneys, European Patent Attorney.

Andrew read molecular biology and biochemistry at Durham University and obtained a DPhil from Oxford University in the area of signal transduction and molecular biology, before moving into patent law.

BSc (Hons), PhD, Fellow of the Chartered Institute of Patent Attorneys, European Patent Attorney.

Mark read chemistry at Sheffield University. He was awarded the Ede and Ravenscroft prize and the Haworth medal for Chemistry for the highest overall marks in his examinations. After completing his studies at Sheffield he went to Cambridge University where he was sponsored by a large pharmaceutical company and obtained a PhD in organic chemistry.

BSc (Hons), Fellow of the Chartered Institute of Patent Attorneys, European Patent Attorney, Member of FICPI and AUTM.

Jane read genetics at the University of Wales, Swansea, choosing to specialise in the areas of human disease genetics and gene therapy technologies. As part of her undergraduate project, Jane conducted a bioinformatics study into individual DNA repair genes and their relationship to the incidences of particular cancer types.

BSc (Hons), PhD, Fellow of the Chartered Institute of Patent Attorneys, European Patent Attorney.

Mark studied microbiology and virology at the University of Warwick and obtained a PhD in Molecular Cell Biology at the same university. His studies included placements in research departments of several multinational pharmaceutical companies in the UK and Austria.

BSc (Hons), PhD, Fellow of the Chartered Institute of Patent Attorneys, European Patent Attorney.

Rob read chemistry at the University of Bristol before obtaining a PhD in organometallic chemistry from the same university. He then spent three years as a post-doctoral scientist at a multinational petrochemical company in The Netherlands and at Imperial College, London.

BSc (Hons), PhD, Fellow of the Chartered Institute of Patent Attorneys, Licensed Israeli Patent Attorney, European Patent Attorney.

Richard read molecular biology at the University of Manchester followed by a PhD in genetics at the University of Cambridge. Richard worked as a post-doctoral scientist in the biotechnology industry for a year before joining the patent profession in Israel in 1998 where he qualified as an Israeli Patent Attorney.

MA (Cantab), DPhil, Fellow of the Chartered Institute of Patent Attorneys, European Patent Attorney.

Sheena read natural sciences (biochemistry) at Cambridge University before obtaining a DPhil in immunology at Oxford University. After working as a Junior Research Fellow, she went on to do three years of postdoctoral research in microbial pathogenesis at Imperial College London. Sheena has authored a dozen papers and reviews in the fields of immunology and microbiology.

MA (Cantab), MSc, PhD, Fellow of the Chartered Institute of Patent Attorneys, European Patent Attorney.

Michael read natural sciences (biochemistry) at Cambridge University before obtaining a PhD in biochemistry at the same university, where a large multinational pharmaceutical company sponsored his research. His research involved using metabolic profiling techniques to study a childhood neurodegenerative disease. During his PhD, he authored several papers in the field of functional genomics.

BSc (Hons), PhD, Fellow of the Chartered Institute of Patent Attorneys.

Ross studied medical microbiology at the University of Edinburgh and subsequently obtained a PhD in molecular biology and biochemistry at the London School of Hygiene and Tropical Medicine. His research involved studying cellular signalling and sexual development in the malaria parasite.

BSc (Hons), PhD, Fellow of the Chartered Institute of Patent Attorneys, European Patent Attorney.

Andy read applied microbiology at the University of Nottingham, before teaching secondary-level science overseas.  Upon returning to the UK he undertook a PhD in Molecular Microbiology at the Institute of Infection, Immunity and Inflammation (University of Nottingham).

BSc (Hons), PhD, Student Member of the Chartered Institute of Patent Attorneys, Member of the Royal Society of Chemistry.

Tony read chemistry with biosciences at Cardiff University, before completing his doctorate in synthetic organic chemistry at the same institution. His research was funded by a multi-national agrochemicals company and his final year presentation was awarded their first prize.

MSci (Hons), PhD, Student Member of the Chartered Institute of Patent Attorneys, Member of the Royal Society of Chemistry.

David read chemistry at the University of Nottingham and continued to complete his doctorate in bioinorganic chemistry at the same institution. His research focussed on the synthesis and characterisation of analogues of molybdenum-containing enzymes, and he was awarded the Turner prize for the most outstanding inorganic chemistry thesis of his year.

BSc (Hons), MSc, Associate of the Chartered Institute of Patent Attorneys. In 2011, Tom was awarded the Nick Wilson Memorial Award for obtaining the highest mark overall in one of the UK qualifying exams.

Tom studied genetics at the University of Nottingham followed by an MSc in applied biomolecular technology at the same university. During his MSc, Tom spent time in industry working on the research and development of novel SNP genotyping assays.

MBiochem (Oxon), PhD, Associate of the Chartered Institute of Patent Attorneys.

Evangelia studied molecular and cellular biochemistry at the University of Oxford before carrying out research in medical genetics at the University of Cambridge. Her research involved identifying novel genetic and pharmacological modifiers of Huntington's disease pathogenesis by using Drosophila disease models. She has authored several scientific papers based on her research.